Contract Manufacturing Resource Center
Insightful integration of Contract Manufacturing Organizations into clinical trial business
VerGo employs Stat-Ease Inc., software to design optimal three-factor experiment
Manufacturing HP active pharmaceutical ingredient drugs is a challenge best met with a thorough assessment of risk and a robust containment strategy
Collaboration in the supply chain will help Pharma stay out in front of the challenges ahead
White Papers: In Depth Research
Posted: Nov 21, 2014
If you are a pharmaceutical company seeking guidance for outsourcing your contract manufacturing, then there are a number of considerations that factor into the decision of where, and how, you will begin the process.
Posted: Oct 28, 2014
While highly potent compounds can have significant benefits in the treatment of certain medical conditions, they present substantial challenges to the pharmaceutical industry.
Posted: Oct 14, 2014
The manufacture of a Highly Potent Active Pharmaceutical Ingredient (HPAPI) compound can present many challenges due to the complex handling required for toxic substances.
Posted: Sep 22, 2014
Metrics are an objective measure of the quality of a product or process, the quality of a site and the effectiveness of systems associated with the manufacture of products, including the pharmaceutical quality systems.